Mishra-Kalyani, Pallavi S.

FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC

Nakajima, E. C., Drezner, N., Li, X., Mishra-Kalyani, P. S., Liu, Y., Zhao, H., Bi, Y., Liu, J., Rahman, A., Wearne, E., et al. (2022) · Clinical Cancer Research

Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics

Cited by 333

FDA analyses of survival in older adults with metastatic non–small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies

Marur, S., Singh, H., Mishra-Kalyani, P., Larkins, E., Keegan, P., Sridhara, R., Blumenthal, G. M., & Pazdur, R. (2018) · Seminars in Oncology

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 100